Paul Po-Sheng Cheng, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheng’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A138665 · Current
Licensed to practise in California · since 2015 · expires 2027-07-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$35,394
Medicare paid this office $35,394 for 280 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 47 | $7,910 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $7,176 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,026 | $155 |
| New patient visit (60+ min) | 19 | $2,942 | $155 |
| Long return visit (40+ min) | 13 | $2,389 | $171 |
See all 11 services
| Long return visit (40+ min) | 47 | $7,910 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $7,176 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,026 | $155 |
| New patient visit (60+ min) | 19 | $2,942 | $155 |
| Long return visit (40+ min) | 13 | $2,389 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,091 | $116 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,768 | $104 |
| Return visit (30+ min) | 15 | $1,315 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 101 | $557 | $5 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 14 | $225 | $15 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $219 | $20 |
Who their Medicare patients are
280 Original Medicare patients in 2024. Average age 76 · Under 65 10% · 85 and older 20% · Women 52% · Also on Medicaid 36% · Health risk score 2.83. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 59% · Heart failure 54% · Atrial fibrillation 48% · Chronic kidney disease 45% · Diabetes 44% · Cancer 30% · Depression 28% · COPD 21% · Dementia 19% · Stroke 18%.
The office billed $130,864, Medicare allowed $46,097 and paid $35,394; for 429 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 280 | 429 | 76 | 2.83 | $130,864 | $35,394 |
| 2023 | 481 | 678 | 74 | 2.54 | $153,564 | $39,592 |
| 2022 | 176 | 322 | 75 | 2.88 | $133,146 | $34,301 |
| 2021 | 146 | 317 | 76 | 2.25 | $137,701 | $32,904 |
| 2020 | 42 | 89 | 76 | 1.60 | $36,230 | $9,442 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 43 | $7,846 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,363 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,318 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,946 | $120 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,641 | $107 |
| New patient visit (60+ min) | 21 | $3,507 | $167 |
| Return visit (30+ min) | 27 | $2,710 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 301 | $2,498 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,335 | $73 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $407 | $24 |
2022: 8 services
| Long return visit (40+ min) | 45 | $8,287 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,526 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,124 | $121 |
| New patient visit (60+ min) | 22 | $3,394 | $154 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,501 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,495 | $64 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,125 | $97 |
| Return visit (30+ min) | 18 | $1,697 | $81 |
2021: 10 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,394 | $183 |
| Long return visit (40+ min) | 23 | $3,739 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,595 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,583 | $65 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,366 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,117 | $94 |
| Return visit (30+ min) | 19 | $2,087 | $91 |
| Initial hospital observation care per day, typically 50 minutes | 15 | $1,958 | $131 |
| New patient visit (60+ min) | 11 | $1,871 | $170 |
| Hospital observation care on day of discharge | 16 | $1,143 | $71 |
2020: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,204 | $67 |
Medicaid work
$808 in 2024
Medicaid paid $808 for 73 billed services this clinician did in 2024, up to 70 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 73 | $808 |
| 2024 | 73 | 1 | 70 | $808 |
| 2023 | 318 | 3 | 106 | $4,667 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 273 | $2,521 |
| Long return visit (40+ min) | 28 | $1,325 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 17 | $821 |
Drugs they prescribed that Part D paid
$582,413
Pharmacies billed $582,413 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 765) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
542 generic and 223 brand-name prescriptions · $582,413 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 13 | $304,139 | $23,395 |
| Eliquis | 87 | $102,052 | $1,173 |
| Entresto | 44 | $77,627 | $1,764 |
| Jardiance | 46 | $59,771 | $1,299 |
| Metoprolol | 62 | $1,543 | $25 |
See all 16 drugs
| Vyndamax | 13 | $304,139 | $23,395 |
| Eliquis | 87 | $102,052 | $1,173 |
| Entresto | 44 | $77,627 | $1,764 |
| Jardiance | 46 | $59,771 | $1,299 |
| Metoprolol | 62 | $1,543 | $25 |
| Carvedilol | 85 | $1,010 | $12 |
| Rosuvastatin | 39 | $922 | $24 |
| Ezetimibe | 11 | $680 | $62 |
| Losartan | 55 | $407 | $7 |
| Atorvastatin | 44 | $397 | $9 |
| Spironolactone | 30 | $356 | $12 |
| Isosorbide Mononitrate Er | 14 | $166 | $12 |
| Clopidogrel | 21 | $150 | $7 |
| Furosemide | 28 | $51 | $2 |
| Amlodipine Besylate | 16 | $45 | $3 |
| Hydrochlorothiazide | 16 | $35 | $2 |
Year by year
| 2024 | 765 | 100 | 0% (0) | 29% | $582,413 |
| 2023 | 624 | 107 | None | 27% | $262,955 |
| 2022 | 459 | 68 | 0% (0) | 22% | $132,621 |
| 2021 | 275 | 58 | 0% (0) | 23% | $49,045 |
| 2020 | 31 | 13 | 0% (0) | None | $6,112 |
| 2019 | 11 | None | 0% (0) | None | $7,146 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Eliquis | 81 | $100,756 | $1,244 |
| Entresto | 29 | $59,408 | $2,049 |
| Jardiance | 38 | $57,869 | $1,523 |
| Carvedilol | 58 | $1,090 | $19 |
| Metoprolol | 36 | $980 | $27 |
| Amiodarone | 12 | $954 | $80 |
| Ezetimibe | 12 | $949 | $79 |
| Rosuvastatin | 28 | $914 | $33 |
| Diltiazem 24hr Er (Cd) | 16 | $901 | $56 |
| Atorvastatin | 41 | $801 | $20 |
| Losartan | 48 | $664 | $14 |
| Sotalol | 13 | $502 | $39 |
| Isosorbide Mononitrate Er | 14 | $419 | $30 |
| Amlodipine Besylate | 23 | $362 | $16 |
| Spironolactone | 21 | $319 | $15 |
| Clopidogrel | 17 | $301 | $18 |
| Furosemide | 25 | $220 | $9 |
2022: 15 drugs
| Eliquis | 43 | $53,418 | $1,242 |
| Jardiance | 18 | $27,511 | $1,528 |
| Xarelto | 11 | $17,109 | $1,555 |
| Metoprolol | 29 | $1,294 | $45 |
| Rosuvastatin | 15 | $1,248 | $83 |
| Losartan | 48 | $665 | $14 |
| Atorvastatin | 38 | $629 | $17 |
| Carvedilol | 26 | $533 | $21 |
| Clopidogrel | 18 | $456 | $25 |
| Spironolactone | 15 | $298 | $20 |
| Amlodipine Besylate | 37 | $294 | $8 |
| Furosemide | 27 | $264 | $10 |
| Isosorbide Mononitrate Er | 12 | $234 | $19 |
| Lisinopril | 13 | $102 | $8 |
| Hydrochlorothiazide | 15 | $28 | $2 |
2021: 13 drugs
| Eliquis | 17 | $18,424 | $1,084 |
| Entresto | 16 | $10,189 | $637 |
| Metoprolol | 11 | $419 | $38 |
| Atorvastatin | 22 | $371 | $17 |
| Clopidogrel | 11 | $296 | $27 |
| Losartan | 17 | $276 | $16 |
| Carvedilol | 18 | $243 | $14 |
| Furosemide | 17 | $225 | $13 |
| Isosorbide Mononitrate Er | 13 | $205 | $16 |
| Nitroglycerin | 12 | $197 | $16 |
| Amlodipine Besylate | 17 | $108 | $6 |
| Lisinopril | 15 | $93 | $6 |
| Hydrochlorothiazide | 11 | $90 | $8 |
Money from drug and device companies
$25 in 2025
| 2025 | 1 | 1 | None | $25 |
| 2024 | 2 | 2 | None | $78 |
| 2023 | 1 | 2 | None | $43 |
| 2022 | 1 | 1 | None | $13 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alnylam Pharmaceuticals | None | $25 | 1 payment
|
See the published payment
| Alnylam Pharmaceuticals | Meals · 2025-05-28 | None | $25 |
See earlier years (2024, 2023, 2022)
2024: $78
| Alnylam Pharmaceuticals | None | $59 | 1 payment
|
| Pfizer | Vyndaqel | $19 | 1 payment
|
2023: $43
| Pfizer | Vyndaqel | $43 | 2 payments
|
2022: $13
| Pfizer | Vyndaqel | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1972923878
- Licence
- CA A138665California A138665: Current · expires 2027-07-31
- Trained
- University of California, San Francisco School of Medicine, 2014
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-04-18
- NPI last updated
- 2024-04-14
- NPI record certified
- 2024-04-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.